NMPA Approval

Desvenlafaxine Succinate Sustained-release Tablets

Approval Number

国药准字H20253251

Company宜昌人福药业有限责任公司

Registration Date

January 24, 2025

Drug Information

Generic Name

琥珀酸地文拉法辛缓释片

Dosage Form

片剂

Strength

按C₁₆H₂₅NO₂计 100mg

Drug Type

化学药品

Registration Date

January 24, 2025

Company Information

Applicant Company

Company Name宜昌人福药业有限责任公司

Company Address

湖北省宜昌开发区大连路19号

Manufacturing Company

Company Name宜昌人福药业有限责任公司

Company Address

湖北省宜昌市东临路519号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

琥珀酸地文拉法辛缓释片 - NMPA 批准文号 | MedPath